Search Prime Grants

HU00012120090

Cooperative Agreement

Overview

Grant Description
Randomized controlled trial of ivabradine in long-haul COVID-19.
Funding Goals
NOT APPLICABLE
Place of Performance
Bethesda, Maryland 208144799 United States
Geographic Scope
Single Zip Code
Related Opportunity
NOT APPLICABLE
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/25 to 03/31/26.
Metis Foundation was awarded Ivabradine for Long-Haul COVID-19: RCT Cooperative Agreement HU00012120090 worth $6,603,892 from the Uniformed Services University of the Health Sciences in September 2021 with work to be completed primarily in Bethesda Maryland United States. The grant has a duration of 4 years 6 months and was awarded through assistance program 12.750 Uniformed Services University Medical Research Projects.

Status
(Ongoing)

Last Modified 6/27/25

Period of Performance
9/1/21
Start Date
3/31/26
End Date
95.0% Complete

Funding Split
$6.6M
Federal Obligation
$0.0
Non-Federal Obligation
$6.6M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to HU00012120090

Transaction History

Modifications to HU00012120090

Additional Detail

Award ID FAIN
HU00012120090
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HU0001 USUHS
Funding Office
HU0001 USUHS
Awardee UEI
CYYCLBFLP125
Awardee CAGE
78HT3
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Modified: 6/27/25